Meeting
2020 Genitourinary Cancers Symposium
Advancing age and the risk of adverse pathology at radical prostatectomy in men with biopsy Gleason score 6 prostate cancer.
Authors
Daniel Kim
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA
Daniel Kim , Ming-Hui Chen , Hartwig Huland , Markus Graefen , Derya Tilki , Anthony Victor D'Amico
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 289)
Abstract #
289
Poster Bd #
K17
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Heterogeneity in early oncologic outcomes among men with NCCN intermediate-risk prostate cancer treated with radical prostatectomy.
First Author: Kamyar Ghabili
Poster
2014 Genitourinary Cancers Symposium
What is the optimal management of Gleason score 7 (GS7) prostate cancer (PC) at biopsy? A comparison of disease control for prostatectomy (RP) versus radiation therapy (RT).
First Author: John Morgan Watkins
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.
First Author: Agnieszka Krzyzanowska
Poster
2022 ASCO Genitourinary Cancers Symposium
Outcomes and factors associated with reclassification in a multiethnic cohort enrolled in active surveillance for prostate cancer.
First Author: Denzel Zhu